| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 02/14/2008 | US20080038382 Extracts of Scutellaria for the Treatment of Sars |
| 02/14/2008 | US20080038330 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds of the lower respiratory tract |
| 02/14/2008 | US20080038312 Insertable or implantable medical devices suitable for gene therapy regimens |
| 02/14/2008 | US20080038264 Compositions and methods for the treatment of immune related diseases |
| 02/14/2008 | US20080038247 Diagnostics and Therapeutics for Diseases Associated With G-Protein-Coupled Receptor Gpr39 (Gpr39) |
| 02/14/2008 | US20080038223 WSX-1/P28 as a target for anti-inflammatory responses |
| 02/14/2008 | US20080035141 Aerosolized therapy kit |
| 02/14/2008 | CA2661446A1 Treatment of pulmonary disease conditions |
| 02/14/2008 | CA2660349A1 2-aminobenzoxazole carboxamides as 5ht3 modulators |
| 02/14/2008 | CA2660192A1 Novel enantiomeric pure beta agonists, method of manufacture and use as a medicament thereof |
| 02/14/2008 | CA2660186A1 Pharmaceutical combinations for the treatment of respiratory diseases |
| 02/14/2008 | CA2659967A1 Quinazoline derivatives |
| 02/14/2008 | CA2659599A1 Amino alcohol derivative and immunosuppressive agent having same as an active ingredient |
| 02/14/2008 | CA2659598A1 Amino phosphate derivative and s1p receptor modulator having same as an active ingredient |
| 02/13/2008 | EP1887082A2 TADG-15: An extracellular serine protease overexpressed in carcinomas |
| 02/13/2008 | EP1887016A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
| 02/13/2008 | EP1887015A2 Method for extracting and using new human defence agents and biologically active proteins for treating infections and other illnesses |
| 02/13/2008 | EP1887008A1 Thienotriazolodiazepine compound and a medicinal use thereof |
| 02/13/2008 | EP1887007A2 Novel compounds |
| 02/13/2008 | EP1887000A1 Arylacetate derivative having isoxazole skeleton |
| 02/13/2008 | EP1886681A2 New nuclear transcription factors regulators |
| 02/13/2008 | EP1885684A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta-2 adrenergic receptor |
| 02/13/2008 | EP1885402A2 Antibodies against mammalian metapneumovirus |
| 02/13/2008 | EP1885348A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
| 02/13/2008 | EP1678175B1 Medical use of zwitterionic compounds being cftr channel modulators |
| 02/13/2008 | EP1480973B1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 02/13/2008 | EP1463716B1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 02/13/2008 | EP1441701B1 Montelukast granule formulation |
| 02/13/2008 | EP1404650B1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 02/13/2008 | EP1303272B1 Benzothiazole derivatives for the treatment of alzheimer's disease and parkinson's disease |
| 02/13/2008 | CN101124198A Medicine compound and composition |
| 02/13/2008 | CN101120995A Method for making traditional Chinese medicine decoction for treating serious edema caused by pulmonary heart disease |
| 02/13/2008 | CN101120962A Application of total salvianolic acid in preparing medicine for treating pulmonary fibrosis |
| 02/13/2008 | CN101120957A Traditional Chinese medicine composition for treating respiratory system infection and preparation technology thereof |
| 02/13/2008 | CN101120938A Application of chlorogenic acid in preparing medicine for treating small cell lung cancer |
| 02/13/2008 | CN100368430C Solasodine hydrofluoric acid salt and its preparation method and its uses in medicine |
| 02/13/2008 | CN100368429C Solasodine hydriodate and its preparation method and its uses in medicine |
| 02/13/2008 | CN100368413C Composition stable blood porphrin derivative, its preparation method and injection agent |
| 02/13/2008 | CN100368411C 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| 02/13/2008 | CN100368410C Micronized crystalline tiotropium bromide |
| 02/13/2008 | CN100368394C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 02/13/2008 | CN100368014C Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 02/13/2008 | CN100367977C Whorlleaf stonecrop herb extract and its extraction process and prepn |
| 02/13/2008 | CN100367973C Drying material and producing method thereof |
| 02/13/2008 | CN100367968C Yinhuang (honeysuckle and Rdix astragali) soft capsule pharmaceutics and preparation process thereof |
| 02/13/2008 | CN100367957C Abiduoer and its salts prepns. for vena administration, and its preparing method |
| 02/13/2008 | CN100367954C Andrographolide soft capsule formulation and preparation method |
| 02/13/2008 | CN100367946C Gabapentin analogues for fibromy algia and other disorders |
| 02/13/2008 | CN100367939C Shangshan dripping pill for treating toxic heat and internal storage and its preparing method |
| 02/13/2008 | CN100367937C Throat dripping pill for clearing away heat and toxic material and its preparing method |
| 02/13/2008 | CN100367936C Oral drop pill in use for clearing sway heat and toxic material, relieving inflammation and dysentery, and preparation method |
| 02/13/2008 | CN100367935C Oral drop pills in use for treating diseases of bacterial infection and preparation method |
| 02/13/2008 | CN100367934C Yin-nourishing lung-heat clearing drop pills |
| 02/12/2008 | US7329777 Methods for treating heart failure, thromboembolic disorders, and pulmonary fibrosis |
| 02/12/2008 | US7329755 especially naphthalene sulfonamides, used for treating asthma |
| 02/12/2008 | US7329753 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 02/12/2008 | US7329686 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 02/12/2008 | US7329676 2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors |
| 02/12/2008 | US7329675 Substituted azabicyclic compounds |
| 02/12/2008 | US7329672 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 02/12/2008 | US7329671 N2,N4-bis(3-hydroxyphenyl)-5-fluoro-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 02/12/2008 | US7329657 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 02/12/2008 | US7329500 Moraxella (Branhamella) catarrhalis polypeptides and corresponding DNA fragments |
| 02/12/2008 | US7329409 Immunology response intensifiers; administering a bacterial lysate, for inducing an immune response to Staphylococcus aureus infections |
| 02/12/2008 | CA2427583C Inhalable formulation of a solution containing a tiotropium salt |
| 02/12/2008 | CA2303432C Modulation of drug loading in multivesicular liposomes |
| 02/12/2008 | CA2133982C Ligand for the c-kit receptor and methods of use thereof |
| 02/07/2008 | WO2008016175A1 Activator for peroxisome proliferator activated receptor |
| 02/07/2008 | WO2008016006A1 Compound having cyclic group bound thereto through spiro binding and use thereof |
| 02/07/2008 | WO2008015437A1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
| 02/07/2008 | WO2008015416A1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
| 02/07/2008 | WO2008015335A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 02/07/2008 | WO2008014814A1 Combination andolast/glucocorticoids |
| 02/07/2008 | WO2008014564A1 Methods and compositions for inhibiting angiogenesis |
| 02/07/2008 | WO2007133796A3 Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist |
| 02/07/2008 | US20080033170 Novel compounds |
| 02/07/2008 | US20080033165 2-(3-(2-phenyloxazolidin-4-on-3-yl)-4-(2-styryl)-azetidin-2-on-1-yl) alkanedioic acid derivatives and corresponding alkoxyalkanoic acid derivatives; treating psychological disorders, cardiovascular disorders |
| 02/07/2008 | US20080033061 Cation conducting gabaa receptors and their use |
| 02/07/2008 | US20080033038 Compositions of polyphenols and methods of use |
| 02/07/2008 | US20080033033 8-azaprostaglandin derivatives and medical use thereof |
| 02/07/2008 | US20080033028 Such as (+/-)-[9-(4-chlorobenzyl)-6-fluoro-8-methanesulfonyl-2, 3,4,9-tetrahydro-1H-carbazol-1-yl]acetic acid; prostaglandin receptor antagonists; antihistamines; nasal decongestion, rhinitis |
| 02/07/2008 | US20080033013 Pyrazolylphenyl and pyrrolylphenyl inhibitors of lta4h for treating inflammation |
| 02/07/2008 | US20080033010 Combination therapy of erdosteine and beta-2 agonists for treating respiratory pathologies characterized by non reversible or partially reversible airway obstruction |
| 02/07/2008 | US20080032997 (5S)-5-methyl-5-({[6-[2-(trifluoromethyl)pyrimidin-5-yl]-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)imidazolidine-2,4-dione; asthma, rhinitis, chronic obstructive pulmonary diseases (COPD), arthritis (such as rheumatoid arthritis and osteoarthritis), atherosclerosis, cancer |
| 02/07/2008 | US20080032969 Novel compounds |
| 02/07/2008 | US20080032960 PI3 kinase antagonists |
| 02/07/2008 | US20080032932 Method of reducing mortality and morbidity associated with critical illnesses |
| 02/07/2008 | US20080032928 Treatment of mucus hypersecretion |
| 02/07/2008 | US20080032342 Chimeric immunogens |
| 02/07/2008 | US20080031936 Immunostimulatory nucleic acid molecules |
| 02/07/2008 | US20080031875 Treatment method |
| 02/07/2008 | US20080031865 Product and process for liquefaction of mucus or sputum |
| 02/07/2008 | US20080031851 Using a reovirus and chemotherapeutic agents to treat ras-activated neoplastic cells; proliferative disorders |
| 02/07/2008 | US20080031824 Swellable particles for drug delivery |
| 02/07/2008 | CA2659542A1 Methods and compositions for inhibiting angiogenesis |
| 02/07/2008 | CA2659539A1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
| 02/07/2008 | CA2659435A1 Combination andolast/glucocorticoids |
| 02/07/2008 | CA2658799A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 02/06/2008 | EP1339712B1 3-substituted quinuclidines and their use as nicotinic agonists |
| 02/06/2008 | EP1309596B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |